Dynavax Technologies (DVAX) Operating Leases (2019 - 2025)
Historic Operating Leases for Dynavax Technologies (DVAX) over the last 7 years, with Q3 2025 value amounting to $28.2 million.
- Dynavax Technologies' Operating Leases fell 917.18% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 million, marking a year-over-year decrease of 917.18%. This contributed to the annual value of $30.6 million for FY2024, which is 1067.63% down from last year.
- Latest data reveals that Dynavax Technologies reported Operating Leases of $28.2 million as of Q3 2025, which was down 917.18% from $28.8 million recorded in Q2 2025.
- Dynavax Technologies' 5-year Operating Leases high stood at $34.9 million for Q3 2021, and its period low was $27.5 million during Q2 2024.
- Over the past 5 years, Dynavax Technologies' median Operating Leases value was $32.1 million (recorded in 2023), while the average stood at $31.7 million.
- Per our database at Business Quant, Dynavax Technologies' Operating Leases crashed by 1290.85% in 2024 and then skyrocketed by 480.47% in 2025.
- Dynavax Technologies' Operating Leases (Quarter) stood at $34.3 million in 2021, then decreased by 4.41% to $32.8 million in 2022, then increased by 4.31% to $34.2 million in 2023, then decreased by 10.68% to $30.6 million in 2024, then decreased by 7.78% to $28.2 million in 2025.
- Its Operating Leases stands at $28.2 million for Q3 2025, versus $28.8 million for Q2 2025 and $29.6 million for Q1 2025.